1. Home
  2. NTRA vs GGG Comparison

NTRA vs GGG Comparison

Compare NTRA & GGG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • GGG
  • Stock Information
  • Founded
  • NTRA 2003
  • GGG 1926
  • Country
  • NTRA United States
  • GGG United States
  • Employees
  • NTRA N/A
  • GGG N/A
  • Industry
  • NTRA Medical Specialities
  • GGG Fluid Controls
  • Sector
  • NTRA Health Care
  • GGG Industrials
  • Exchange
  • NTRA Nasdaq
  • GGG Nasdaq
  • Market Cap
  • NTRA 20.6B
  • GGG 13.8B
  • IPO Year
  • NTRA 2015
  • GGG N/A
  • Fundamental
  • Price
  • NTRA $159.83
  • GGG $83.31
  • Analyst Decision
  • NTRA Strong Buy
  • GGG Buy
  • Analyst Count
  • NTRA 15
  • GGG 4
  • Target Price
  • NTRA $152.67
  • GGG $89.25
  • AVG Volume (30 Days)
  • NTRA 1.1M
  • GGG 673.1K
  • Earning Date
  • NTRA 02-26-2025
  • GGG 01-27-2025
  • Dividend Yield
  • NTRA N/A
  • GGG 1.21%
  • EPS Growth
  • NTRA N/A
  • GGG N/A
  • EPS
  • NTRA N/A
  • GGG 2.83
  • Revenue
  • NTRA $1,531,955,000.00
  • GGG $2,131,288,000.00
  • Revenue This Year
  • NTRA $53.71
  • GGG N/A
  • Revenue Next Year
  • NTRA $11.00
  • GGG $4.30
  • P/E Ratio
  • NTRA N/A
  • GGG $29.79
  • Revenue Growth
  • NTRA 54.94
  • GGG N/A
  • 52 Week Low
  • NTRA $58.53
  • GGG $77.49
  • 52 Week High
  • NTRA $175.63
  • GGG $94.77
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 51.07
  • GGG 39.51
  • Support Level
  • NTRA $155.12
  • GGG $83.14
  • Resistance Level
  • NTRA $161.53
  • GGG $84.85
  • Average True Range (ATR)
  • NTRA 5.56
  • GGG 1.25
  • MACD
  • NTRA -1.63
  • GGG -0.30
  • Stochastic Oscillator
  • NTRA 37.59
  • GGG 20.10

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About GGG Graco Inc.

Graco manufactures equipment used for managing fluids, coatings, and adhesives, specializing in difficult-to-handle materials. Graco's business is organized into three segments: industrial, process, and contractor. The Minnesota-based firm serves a wide range of end markets, including industrial, automotive, and construction, and its broad array of products include pumps, valves, meters, sprayers, and equipment used to apply coatings, sealants, and adhesives. The firm generated roughly $2.2 billion in sales in 2023.

Share on Social Networks: